Announcements Trials
Browse Landscape

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Myeloid 1Dermatologic 1

Conditions

Neoplasms 276Breast Neoplasms 266Lung Neoplasms 127Prostatic Neoplasms 124Colorectal Neoplasms 105Carcinoma, Non-Small-Cell Lung 104Pancreatic Neoplasms 70Carcinoma, Hepatocellular 58Stomach Neoplasms 55Hematologic Neoplasms 52Urinary Bladder Neoplasms 50Multiple Myeloma 50Ovarian Neoplasms 49Brain Neoplasms 49Esophageal Neoplasms 46Leukemia, Myeloid, Acute 45Melanoma 44Head and Neck Neoplasms 42Colonic Neoplasms 41Disease 40Neoplasm Metastasis 39Liver Neoplasms 39Rectal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma 32Uterine Cervical Neoplasms 31Endometrial Neoplasms 30Thyroid Neoplasms 29Recurrence 29Leukemia, Lymphocytic, Chronic, B-Cell 29

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Arthritis, Rheumatoid × 90 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

NCT02450396 2026-03-27

EGR2

Assistance Publique - Hôpitaux de Paris

Withdrawn
Myeloid

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Mastocytosis, Myositis, Sjogren's Syndrome, Vasculitis, Arthritis, Psoriatic, Antiphospholipid Syndrome, Spondylarthritis, Rare Diseases, Scleroderma, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡